尽管净亏损较大,但电力核心公司的收入在2025年增长了27%,预计到2026年将增长30%. electroCore grew revenue 27% in 2025, projects 30% growth in 2026 despite a larger net loss.

电力公司报告了强的2025财务业绩, 年收入为3200万美元, 同比增长27%, 受越来越多的医疗器械处方和健康产品销售推动. electroCore reported strong 2025 financial results with $32 million in annual revenue, a 27% year-over-year increase, driven by growth in VA channel prescriptions and wellness product sales. 由于SG&A费用上升,公司年终净亏损1400万美元,较1190万美元增加,但毛利率提高到87%. The company ended the year with a net loss of $14 million, up from $11.9 million, due to rising SG&A expenses, but improved gross margins to 87%. 领导层的变化包括首席执行官丹尼尔·戈德伯格2026年4月1日退休,约书亚·列夫被任命为临时总裁和CFO,迈克尔·福克斯加入COO. Leadership changes include CEO Daniel Goldberger’s retirement effective April 1, 2026, with Joshua Lev named interim President and CFO and Michael Fox joining as COO. 该公司预计2026年收入增长30%,得到了Quell Relief (OTC) 软推出,继续扩大VA市场以及向凯撒配方纳入的进展. The company projects 30% revenue growth in 2026, supported by a soft launch of Quell Relief (OTC), continued VA market expansion, and progress toward Kaiser formulary inclusion.